Miller Financial Services
IRD icon

Miller Financial Services’s Opus Genetics IRD Stock Holding History

Miller Financial Services’s Portfolio IRD Stock Details IRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$145K Buy
30,000
+3,000
+11% +$12.5K 0.11% 136
2026
Q2 		$111K Buy
27,000
+5,000
+23% +$23.3K 0.09% 134
2026
Q1 		$100K Buy
22,000
+12,000
+120% +$41.5K 0.11% 112
2025
Q4 		$20.1K Buy
+10,000
New +$20.3K 0.02% 113

Other funds holding IRD

Empirical Wealth Management
Empirical Wealth Management Seattle, Washington $7.38B AUM 22.9% 1-Year Est. Return
James Investment Research
James Investment Research Alpha, Ohio $936M AUM 24.49% 1-Year Est. Return
Sanders Morris Harris
Sanders Morris Harris Houston, Texas $755M AUM 11.28% 1-Year Est. Return
First City Capital Management
First City Capital Management Savannah, Georgia $204M AUM 20.28% 1-Year Est. Return
Concurrent Investment Advisors
Concurrent Investment Advisors Tampa, Florida $14.5B AUM 24.52% 1-Year Est. Return
Hilton Head Capital Partners
Hilton Head Capital Partners Hilton Head Island, South Carolina $185M AUM 26.97% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
Sterling Capital Management
Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
SJS Investment Consulting
SJS Investment Consulting Sylvania, Ohio $993M AUM 16.29% 1-Year Est. Return

Miller Financial Services's IRD Position: Q3 2026 in Review

Miller Financial Services increased its Opus Genetics (IRD) stake by 11% in Q3 2026, buying an estimated $12.5K and bringing the position to 30,000 shares worth $145K. The position accounts for 0.11% of the portfolio, ranked #136.

Miller Financial Services first reported a position in IRD in Q4 2025 and has held it in 4 quarters since. 13 funds tracked by Wall St. Rank hold IRD as of Q3 2026.

  • Miller Financial Services held 30,000 shares of Opus Genetics worth $145K as of Q3 2026.
  • Miller Financial Services bought 3,000 Opus Genetics shares in Q3 2026, an estimated $12.5K.
  • Opus Genetics made up 0.11% of Miller Financial Services's portfolio in Q3 2026, its #136 holding.
  • Miller Financial Services first reported a position in Opus Genetics in Q4 2025 and has held it in 4 quarters since.
  • 13 funds tracked by Wall St. Rank held Opus Genetics as of Q3 2026.

Based on Miller Financial Services's 13F filing for Q3 2026, filed 20 Oct 2026.